M. Pedersen

Human GIP(3‐30)NH2 inhibits G protein‐dependent as well as G protein‐independent signaling and is selective for the GIP receptor with high‐affinity binding to primate but not rodent GIP receptors

M. Rosenkilde, B. Hartmann, A. Inoue, 2018, Biochemical pharmacology.

Dissecting the roles of GRK2 and GRK3 in μ-opioid receptor internalization and β-arrestin2 recruitment using CRISPR/Cas9-edited HEK293 cells

J. M. Mathiesen, M. Bouvier, H. Bräuner‐Osborne, 2020, Scientific Reports.

Structural insights into differences in G protein activation by family A and family B GPCRs

J. M. Mathiesen, G. Skiniotis, B. Kobilka, 2020, Science.

Structural insights into ligand efficacy and activation of the glucagon receptor

J. M. Mathiesen, G. Skiniotis, B. Kobilka, 2019, bioRxiv.

Biased agonism of clinically approved μ-opioid receptor agonists and TRV130 is not controlled by binding and signaling kinetics

S. Foster, M. Bouvier, H. Bräuner‐Osborne, 2020, Neuropharmacology.